Publikationen

Zaeck, L. M., Lamers, M. M., Verstrepen, B. E., Bestebroer, T. M., van Royen, M. E., Götz, H., Shamier, M. C., van Leeuwen, L. P. M., Schmitz, K. S., Alblas, K., van Efferen, S., Bogers, S., Scherbeijn, S., Rimmelzwaan, G. F., van Gorp, E. C. M., Koopmans, M. P. G., Haagmans, B. L., GeurtsvanKessel, C. H., & de Vries, R. D. (2023). Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nature Medicine, 29(1), 270–278. https://doi.org/10.1038/s41591-022-02090-w
Details anzeigen

Jansen, J. M. (2022). T cell-mediated immunity to influenza virus and SARS-CoV-2: effect of host adaptation and aging. https://elib.tiho-hannover.de/receive/tiho_mods_00007690
Details anzeigen

Jonczyk, R., Stanislawski, N., Seiler, L. K., Ahani, S., Bueltemeier, A., Stahl, F., Beutel, S., Blume, H., Hauß, C., Melk, A., Paulsen, M., Stiesch, M., Winkel, A., Pott, P.-C., Saletti, G., González-Hernández, M., Kaiser, F. K., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Blume, C. (2022). Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity. Journal of Clinical Virology, 157. https://doi.org/10.1016/j.jcv.2022.105322
Details anzeigen

Jonczyk, R., Stanislawski, N., Seiler, L. K., Blume, H., Heiden, S., Lucas, H., Sarikouch, S., Pott, P.-C., Stiesch, M., Hauß, C., Saletti, G., González-Hernández, M., Kaiser, F. K., Rimmelzwaan, G., Osterhaus, A., & Blume, C. (2022). Combined prospective seroconversion and PCR data of selected cohorts indicate a high rate of subclinical SARS-CoV-2 infections: an open observational study in Lower Saxony, Germany. Microbiology Spectrum / American Society for Microbiology, 10(1). https://doi.org/10.1128/spectrum.01512-21
Details anzeigen

Lombardo, M. S., de le Roi, M., Postel, A., King, J., Kaiser, F., K., Kennedy, J., Reineking, W., Harder, T., Pohlmann, A., Gerlach, T., Rimmelzwaan, G., Rohner, S., Striewe, L. C., Gross, S., Schick, L. A., Klink, J. C., Kramer, K., Osterhaus, A. D. M. E., Beer, M., … Baumgärtner, W. (2022). Infektion des zentralen Nervensystems mit aviärem Influenza-A-Virus des Subtyps H5N8 in Seehunden (Phoca vitulina) an der deutschen Nordseeküste. In Tierärztliche Praxis / G. Thieme. https://doi.org/10.1055/s-0042-1749978
Details anzeigen

Lombardo, M. S., de le Roi, M., Postel, A., King, J., Kaiser, F. K., Kennedy, J., Reineking, W., Harder, T., Pohlmann, A., Gerlach, T., Rimmelzwaan, G., Rohner, S., Striewe, L. C., Groß, S., Schick, L. A., Klink, J. C., Kramer, K., Osterhaus, A., Beer, M., … Baumgärtner, W. (2022). Infektion des zentralen Nervensystems mit aviärem Influenza-A-Virus des Subtyps H5N8 in Seehunden (Phoca vitulina) an der deutschen Nordseeküste. In A. Beineke (Ed.), 65. Jahrestagung und 27. Schnittseminar der DVG-Fachgruppe Pathologie. Verlag der DVG-Service.
Details anzeigen

Meineke, R. (2022). Inhibition of Host Kinase Activity: Effects on Influenza A Virus Infection and Host Cell Signaling. https://elib.tiho-hannover.de/receive/tiho_mods_00007171
Details anzeigen

Meineke, R., Stelz, S., Busch, M., Werlein, C., Kühnel, M., Jonigk, D., Rimmelzwaan, G. F., & Elbahesh, H. (2022). FDA-approved inhibitors of RTK/Raf signaling potently impair multiple steps of in vitro and ex vivo influenza A virus infections. Viruses, 14(9). https://doi.org/10.3390/v14092058
Details anzeigen

Michaely, L. M., Schuwerk, L., Allnoch, L., Schön, K., Waltl, I., Larsen, P.-K., Pavlou, A., Prajeeth, C. K., Rimmelzwaan, G. F., Becker, S. C., Kalinke, U., Baumgärtner, W., & Gerhauser, I. (2022). Intact type I interferon receptor signaling prevents hepatocellular necrosis but not encephalitis in a dose-dependent manner in Rift Valley fever virus infected mice. International Journal of Molecular Sciences, 23(20). https://doi.org/10.3390/ijms232012492
Details anzeigen

Oosting, S. F., van der Veldt, A. A. M., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., Bhattacharya, A., de Wilt, F., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., Rots, N. Y., … de Vries, E. G. E. (2022). Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours. The Lancet oncology, 23(7), 833–835. https://doi.org/10.1016/s1470-2045(22)00203-0
Details anzeigen

Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
Details anzeigen

Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen

Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen

Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen

Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen